Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Immunization Access topic
No spam. Unsubscribe anytime.
Senate advances and amends SB32 to expand immunization access while preserving budget oversight
Summary
After extensive debate and multiple floor amendments, the Colorado Senate advanced Senate Bill 32 (promotion of immunization access), adopting compromise language that expands immunization access (including independent prescriptive authority for some providers) while adding budget safeguards to address state fiscal exposure; several liability and parental-consent amendments failed. SB32 passed committee of the whole and was ordered for third reading as amended.
The Colorado Senate advanced Senate Bill 32 on Feb. 4, 2026, after detailed floor debate over funding, liability, parental consent and scope of prescriptive authority for immunizations.
Senator Mullica introduced the Health and Human Services committee report, noting definitions and technical fixes added in committee, removal of redundant pharmacy rulemaking, and authorization for the Colorado Department of Public Health and Environment (CDPHE) to purchase vaccines. Multiple floor amendments were offered and adopted to clarify coverage and supply-chain language.
Floor debate turned to fiscal exposure in a change that would remove an existing statutory prohibition on using state general funds for infant immunization programs if federal funds were not received. Senator Bright argued the repeal could put the state on the hook financially, citing a quick external search that suggested a potential $27,000,000 exposure. Senator Frizzell, who supported reinstating the prohibition via amendment L004, said that the fiscal note did not include the $27 million figure and urged caution; Senator Mulligan and others countered that the bill would not mandate spending but would allow the legislature the option to fund programs if federal dollars were withheld.
An amendment (L004) to reinstate the prohibition was defeated by voice vote. Other proposed amendments included parental-consent language (L005) and changes to liability protections (L006); both L005 and L006 failed on voice votes after extended debate. Senator Frizzell and others pressed concerns that removing liability provisions would limit remedies for vaccine-related injuries; proponents argued liability protections help preserve research and reduce overly litigious pressure on manufacturers and providers.
Senator Kirkmeyer brought a compromise amendment (L012) that modified the language instead of repealing it, clarifying that any additional general fund monies would be addressed through the annual budget process. Senators from both sides described L012 as a responsible compromise to preserve legislative budget authority; L012 was adopted. The committee of the whole reported SB32 as amended and the Senate ordered the bill for third reading and final passage.
A procedural floor amendment (S001) to alter the committee report’s treatment of a prior amendment was put to a recorded vote and failed 12 ayes, 20 no, 3 excused. The body also addressed other appointments and committee business before recessing.
The bill as amended expands which providers may administer or prescribe certain vaccines and updates insurance and liability references; it authorizes CDPHE vaccine purchases and clarifies that state budgeting processes govern any future general fund expenditures. Several substantive issues remain points of contention—chiefly the scope of liability protections and parental-consent requirements—but the passage of L012 preserved legislative control over budget decisions.
Next steps: SB32 was advanced out of the committee of the whole and placed on the calendar for third reading and final passage; timing for final passage was not recorded in the transcript provided.
